scholarly journals Cysteamine bitartrate delayed‐release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open‐label study of treatment‐naïve patients <6 years of age with nephropathic cystinosis

JIMD Reports ◽  
2021 ◽  
Author(s):  
Maria Helena Vaisbich ◽  
Juliana Caires Ferreira ◽  
Heather Price ◽  
Kyleen D. Young ◽  
Saba Sile ◽  
...  
Keyword(s):  
Nephropathic Cystinosis ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Delayed Release ◽  
Treatment Naïve ◽  
Kidney Health

scholarly journals Nocturnal Asthma: Proof-of-Concept Open-Label Study with Delayed-Release Prednisone

2015 ◽  
Vol 1 (1) ◽  
pp. 43-52 ◽  
Author(s):  
Loubna Alavoine ◽  
Camile Taillé ◽  
Julie Ball ◽  
Christine Knauer ◽  
Stephan Witte ◽  
...  
Keyword(s):  
Proof Of Concept ◽  
Open Label ◽  
Nocturnal Asthma ◽  
Open Label Study ◽  
Label Study ◽  
Delayed Release

Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naïve or Experienced Patients

2017 ◽  
Vol 112 (12) ◽  
pp. 1824-1831 ◽  
Author(s):  
Mindie H Nguyen ◽  
Huy Trinh ◽  
Son Do ◽  
Thuan Nguyen ◽  
Pauline Nguyen ◽  
...  
Keyword(s):  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Treatment Naïve

scholarly journals Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study

2017 ◽  
Vol 65 (1) ◽  
pp. 13-19 ◽  
Author(s):  
Jordan J Feld ◽  
Alnoor Ramji ◽  
Stephen D Shafran ◽  
Bernard Willems ◽  
Paul Marotta ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 3 ◽  
Virus Genotype ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Treatment Naïve
Sign in / Sign up

Export Citation Format

Share Document